TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 36.50
-0.50 (-1.35%)
Jul 14, 2026, 12:23 PM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 965.74 million as of July 14, 2026. Its market cap has decreased by -12.57% in one year.
Market Cap
965.74M
Enterprise Value
164.98M
Revenue
273.61M
Ranking
n/a
PE Ratio
24.01
Stock Price
36.50
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 965.74M, a decrease of -54.77%. That is a compound annual growth rate of -16.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 965.74M | 2.82% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.16B |
| LabTurbo Biotech | 1.11B |
| Lukas Biomedical | 1.07B |
| Bio Preventive Medicine | 1.06B |
| Level Biotechnology | 1.03B |
| Holy Stone Healthcare | 1.02B |
| U-Neuron Biomedical | 997.31M |
| GeneReach Biotechnology | 979.88M |